News
banner - lb_DSC_3403

In the news today

Keep up to date with the latest news as it happens . Find out what is happening in the world of pharmaceuticals, legislation and beyond.

MHRA response statement to IMMDS Review report publication


Read more...

Don’t rely on temperature screening products for detection of coronavirus (COVID-19), says MHRA


Read more...

Chloroquine and Hydroxychloroquine not licensed for coronavirus (COVID-19) treatment


Read more...

Green light for COVID-19 trial recruitment


Read more...

MHRA suspends recruitment to COVID-19 hydroxychloroquine trials


Read more...

David Noakes: Judge orders seizure of £1.4 million


Read more...

Action taken to halt sales of fingerprick coronavirus (COVID-19) antibody testing kits


Read more...

MHRA issues a scientific opinion for the first medicine to treat COVID-19 in the UK


Read more...

Patients informed to exchange Emerade 500 micrograms adrenaline pens for a different brand


Read more...

Applications invited for the role of Chair of the MHRA


Read more...

Senior Enforcement Advisor at UK Medicines Regulator warns against purchasing fake or unlicensed coronavirus (COVID-19) medicines


Read more...

New reagent available to support global diagnostic testing of coronavirus (COVID-19)


Read more...

Coronavirus: new website for reporting medicines side effects and equipment incidents


Read more...

MHRA approves COVID-19 vaccine trial in 7 working days


Read more...

Commission on Human Medicines advice on ibuprofen and coronavirus (COVID-19)


Read more...

Patients informed to exchange Emerade 300 micrograms adrenaline pens for replacement pens of a different brand


Read more...

Birmingham pair given suspended prison sentences for selling medicines online illegally


Read more...

UK medicines and medical devices regulator investigating 14 cases of fake or unlicensed COVID-19 medical products


Read more...

MHRA approves new life-saving breathing aid to help keep coronavirus (COVID-19) patients out of intensive care


Read more...

Status of Phase 1 clinical trials in response to coronavirus (COVID-19)


Read more...